Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 110 Records) |
Query Trace: Lymphoma and MYD88[original query] |
---|
Circulating cell-free DNA and IL-10 from cerebrospinal fluids aid primary vitreoretinal lymphoma diagnosis. Frontiers in oncology 2022 9 12 955080. Zhuang Zhe, Zhang Yan, Zhang Xiao, Zhang Meifen, Zou Dongmei, Zhang Li, Jia Congwei, Zhang W |
Clinical significance of MYD88 non-L265P mutations in diffuse large B-cell lymphoma. Hematological oncology 2022 Sep . Xie Jialing, Shen Xia, Shi Qin, Yi Hongmei, Ouyang Binshen, Zhang Zhihan, Gu Yijin, Dong L |
Genomic Mutation Landscape of Primary Breast Lymphoma: Next-Generation Sequencing Analysis. Disease markers 2022 2022 6441139. Zhang Wenqi, Huang Chen, Liu Jingjing, Wu Lili, Zhang Huichao, Wu Xiaolin, Wang Lianjing, Li Weijing, Liu Wei, Liu Liho |
Whole-Genome/Exome Sequencing Uncovers Mutations and Copy Number Variations in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System. Frontiers in genetics 2022 6 13 878618. Zhu Qiong, Wang Jianchao, Zhang Wenfang, Zhu Weifeng, Wu Zaizeng, Chen Yanping, Chen Musheng, Zheng Limei, Tang Jianqing, Zhang Sheng, Wang Di, Wang Xingfu, Chen Ga |
Landscape of immunoglobulin heavy chain gene repertoire and its clinical relevance to LPL/WM. Blood advances 2022 May . Wang Jun, Yan Yuting, Xiong Wenjie, Song Ge, Wang Yi, Zhao Jiawei, Jia Yujiao, Li Chengwen, Yu Zhen, Yu Ying, Chen Jiawen, Jiao Yang, Wang Tingyu, Lyu Rui, Li Qinghua, Ma Yueshen, Liu Wei, Zou Dehui, An Gang, Sun Qi, Wang Huijun, Xiao Zhijian, Wang Jianxiang, Qiu Lugui, Yi Shuh |
De Novo CD5-positive diffuse large B-cell lymphoma: A genomic profiling study and prognostic analysis of 46 patients. Annals of diagnostic pathology 2022 3 58 151886. Fan Yue, Binshen Ouyang, Zhang Zhihan, Yi Hongmei, Zhang Wenjing, Liu Qingxiao, Liu Yang, Dong Lei, Wang Chao |
CD79B Y196 mutation is a potent predictive marker for favorable response to R-MPV in primary central nervous system lymphoma. Cancer medicine 2022 Dec . Yamaguchi Junya, Ohka Fumiharu, Lushun Chalise, Motomura Kazuya, Aoki Kosuke, Takeuchi Kazuhito, Nagata Yuichi, Ito Satoshi, Mizutani Nobuhiko, Ohno Masasuke, Suzaki Noriyuki, Takasu Syuntaro, Seki Yukio, Kano Takahisa, Wakabayashi Kenichi, Oyama Hirofumi, Kurahashi Shingo, Tanahashi Kuniaki, Hirano Masaki, Shimizu Hiroyuki, Kitano Yotaro, Maeda Sachi, Yamazaki Shintaro, Wakabayashi Toshihiko, Kondo Yutaka, Natsume Atsushi, Saito Ryu |
Circulating tumor DNA mutation profile is associated with the prognosis and treatment response of Chinese patients with newly diagnosed diffuse large B-cell lymphoma. Frontiers in oncology 2022 12 12 1003957. Guan Tao, Zhang Min, Liu Xiaolan, Li Jing, Xin Beibei, Ren Yanxin, Yang Yuchao, Wang Hui, Zhao Mengjing, Huang Yunpeng, Guo Xiaojing, Du Jun, Qian Wenbin, Su Lipi |
The evaluation of gene mutation profiles by next-generation sequencing in diffuse large B-cell lymphoma. International journal of laboratory hematology 2022 12 . Özçal?ml? Azime, Erdo?du ?brahim Halil, Turgutkaya Atakan, Yava?o?lu ?rfan, Döger Füruzan Kaçar, Bolaman Ali Zah |
Whole-exome sequencing analysis identifies distinct mutational profile and novel prognostic biomarkers in primary gastrointestinal diffuse large B-cell lymphoma. Experimental hematology & oncology 2022 Oct 11 (1): 71. Li Shan-Shan, Zhai Xiao-Hui, Liu Hai-Ling, Liu Ting-Zhi, Cao Tai-Yuan, Chen Dong-Mei, Xiao Le-Xin, Gan Xiao-Qin, Cheng Ke, Hong Wan-Jia, Huang Yan, Lian Yi-Fan, Xiao Ji |
A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome. Blood advances 2022 Feb . Guney Ekin, Lucas Calixto-Hope G, Qi Zhongxia, Yu Jingwei, Zhang Ruth, Ohgami Robert S, Rubenstein James L, Boué Daniel R, Schafernak Kristian T, Wertheim Gerald B, Dahiya Sonika, Giulino-Roth Lisa, Attarbaschi Andishe, Barth Matthew J, Kothari Shalin, Abla Oussama, Cohen Adam L, Mendez Joe S, Bollen Andrew Wesley, Perry Arie, Tihan Tarik, Pekmezci Melike, Solomon David A, Wen Kwun W |
A pilot study of the use of dynamic cfDNA from aqueous humor and vitreous fluid for the diagnosis and treatment monitoring of vitreoretinal lymphomas. Haematologica 2022 Feb . Wang Xiaoxiao, Su Wenru, Gao Yan, Feng Yanfen, Wang Xiaoxia, Chen Xiaoqing, Hu Yunwei, Ma Yutong, Ou Qiuxiang, Liang Dan, Huang Huiqia |
Genomic profiling of primary diffuse large B-cell lymphoma of the central nervous system suggests novel potential therapeutic targets. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 9 100323. Claudio Agostinelli, Luca Morandi, Simona Righi, Luigi Cirillo, Marica Iommi, Caterina Tonon, Diego Mazzatenta, Matteo Zoli, Maura Rossi, Gianmarco Bagnato, Alessandro Broccoli, Raffaele Lodi, Pier Luigi Zinzani, Elena Sabattini, Caterina Giannini, Sofia Asio |
Efficacy and safety of zanubrutinib plus R-CHOP in treatment of non-GCB DLBCL with extranodal involvement. Frontiers in immunology 2023 9 14 1219167. Hongzhi Geng, Sixun Jia, Ying Zhang, Jiaqi Li, Qin Yang, Liangyu Zeng, Xiangping Zong, Yutong Lu, Shuangzhu Lu, Jin Zhou, Caixia Li, Depei |
Prognostic impact of MYD88 and TP53 mutations in diffuse large B Cell lymphoma. Annals of hematology 2023 9 . Osama Abd El Hameed Ebid, Lobna R Ezz El Arab, Amr S Saad, Mai Ezz El Din, Nermeen Mostafa, Menha Swell |
The Prevalence of MYD88 L265P and TNFAIP3 Mutations and Their Correlations with Clinico-Hematological Profile in Egyptian Patients with Diffuse Large B Cell Lymphoma. Asian Pacific journal of cancer prevention : APJCP 2023 7 24 (7): 2485-2491. Osama Elbaz, Rana M Shaat, Hasan A Abd El Ghaffar, Sameh Shamaa, Hanaa M Abdel-Masseih, Nahla Anber, Metwaly Ibrahim Morta |
Mutations Associated with Progression in Follicular Lymphoma Predict Inferior Outcomes at Diagnosis (Alliance A151303). Blood advances 2023 7 . David A Russler-Germain, Kilannin Krysiak, Cody Ramirez, Matthew Mosior, Marcus P Watkins, Felicia Gomez, Zachary L Skidmore, Lee Trani, Feng Gao, Susan Geyer, Amanda F Cashen, Neha Mehta-Shah, Brad S Kahl, Nancy L Bartlett, Juan Pablo Alderuccio, Izidore S Lossos, Sarah L Ondrejka, Eric D Hsi, Peter Martin, John P Leonard, Malachi Griffith, Obi L Griffith, Todd A Fehnig |
[Clinicopathologic characteristics and prognostic analysis of testicular diffuse large B-cell lymphoma]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023 6 44 (4): 321-327. Y Wang, Z Y Shi, Q Shi, S Wang, M C Zhang, R Shen, Y He, H L Qiu, H M Yi, L Dong, L Wang, S Cheng, P P Xu, W L Zh |
Mutational Profile in 75 Patients With Anti-Myelin-Associated Glycoprotein Neuropathy: Clinical and Hematologic Therapy Response and Hints on New Therapeutic Targets. Neurology(R) neuroimmunology & neuroinflammation 2023 5 10 (4): . Francesca Castellani, Andrea Visentin, Erika Schirinzi, Alessandro Salvalaggio, Mario Cacciavillani, Cinzia Candiotto, Claudia Baratè, Alessandro Cellini, Roberta Bertorelle, Gabriele Siciliano, Livio Trentin, Chiara Bria |
MYD88 and MYD88 variants show different molecular characteristics and prognostic significance in diffuse large B-cell lymphoma. Journal of cancer research and clinical oncology 2023 4 . Yan Qin, Tian Qiu, Zucheng Xie, Xinrui Chen, Peng Liu, Jianliang Yang, Xiaohui He, Lin Gui, Shengyu Zhou, Hongxin Jiang, Changgong Zhang, Sheng Yang, Le Tang, Yuankai S |
MYD88-Mutated Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma as a Distinctive Molecular Subgroup Is Associated with Atypical Immunophenotypes in Chinese Patients. Journal of clinical medicine 2023 4 12 (7): . Mu Yafei, Fan Xijie, Chen Tao, Meng Yuhuan, Lin Junwei, Yuan Jiecheng, Yu Shihui, Chen Yuxin, Liu Lingli |
The outcome of ibrutinib-based regimens in relapsed/refractory central nervous system lymphoma and the potential impact of genomic variants. Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2023 3 . Wang Shu, Zhu Yuqi, Qian Xiaohan, Ding Tianling, Yuan Yan, Li Yuan, Wu Hanfeng, Chen To |
Molecular associations of response to the new generation BTK inhibitor zanubrutinib in marginal zone lymphoma. Blood advances 2023 3 . Tatarczuch Maciej, Waltham Mark, Shortt Jake, Polekhina Galina, Hawkes Eliza A, Ho Shir-Jing, Trotman Judith, Brasacchio Daniella, Co Melannie, Li Jessica, Ramakrishnan Vanitha, Dunne Karin, Opat Stephen S, Gregory Gareth |
Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors. JCO precision oncology 2023 3 7 e2200583. Aldea Mihaela, Tagliamento Marco, Bayle Arnaud, Vasseur Damien, Vergé Véronique, Marinello Arianna, Danlos François-Xavier, Blanc-Durand Felix, Bernard Elsa, Cerbone Luigi, Mosele Maria Fernanda, Renneville Aline, Hadoux Julien, Loriot Yohann, Sakkal Madona, Vozy Aurore, Sarkozy Clementine, Smolenschi Cristina, Nicotra Claudio, Martin-Romano Patricia, Boccon-Gibod Clementine, Habza Wafikaamira, Lazarovici Julien, Ponce Santiago, Hollebecque Antoine, Marzac Christophe, Lacroix Ludovic, Barlesi Fabrice, André Fabrice, Besse Benjamin, Rouleau Etienne, Italiano Antoine, Micol Jean-Baptis |
Waldenström macroglobulinemia and non-IgM-type lymphoplasmacytic lymphoma are genetically similar. Acta haematologica 2023 3 . Awata-Shiraiwa Maaya, Yokohama Akihiko, Kanai Yukihiro, Gotoh Nanami, Kasamatsu Tetsuhiro, Handa Hiroshi, Saitoh Takayuki, Murakami Hirokazu, Hirato Junko, Ikota Hayato, Tsukamoto Norifu |
Whole-Exome Sequencing Revealed the Mutational Profiles of Primary Central Nervous System Lymphoma. Clinical lymphoma, myeloma & leukemia 2023 2 . Zhang Rui, Wei Boyuan, Hu Yiyang, Lv Wenying, Adilai Abudurexiti, Yang Fan, Zhang Jianning, Cheng Ga |
Clonal Relationship and Mutation Analysis in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Associated With Diffuse Large B-cell Lymphoma. HemaSphere 2023 11 7 (11): e976. Madeleine R Berendsen, Diede A G van Bladel, Eva Hesius, Cristina Berganza Irusquieta, Jos Rijntjes, Annemiek B van Spriel, Ellen van der Spek, Johannes F M Pruijt, Leonie I Kroeze, Konnie M Hebeda, Sandra Croockewit, Wendy B C Stevens, J Han J M van Krieken, Patricia J T A Groenen, Michiel van den Brand, Blanca Scheij |
Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study. American journal of hematology 2023 1 . Michot Jean-Marie, Quivoron Cyril, Sarkozy Clémentine, Danu Alina, Lazarovici Julien, Saleh Khalil, El-Dakdouki Yolla, Goldschmidt Vincent, Bigenwald Camille, Dragani Matteo, Bahleda Rastislav, Baldini Capucine, Arfi-Rouche Julia, Martin-Romano Patricia, Tselikas Lambros, Gazzah Anas, Hollebecque Antoine, Lacroix Ludovic, Ghez David, Vergé Veronique, Marzac Christophe, Cotteret Sophie, Rahali Wassila, Soria Jean-Charles, Massard Christophe, Bernard Olivier A, Dartigues Peggy, Camara-Clayette Valérie, Ribrag Vince |
Molecular Biomarker Exploration of Rituximab plus CHOP Therapy in Real-World Diffuse Large B-Cell Lymphoma Patients. Clinical laboratory 2023 1 69 (1): . Wang HongBiao, Lin YingCheng, Li ZhiFeng, Wu YueRong, Yang ZhengYuan, Gao ShiHua, Lin FangFa |
Bone Involvement as a Primary Rare Manifestation of Waldenstrom Macroglobulinemia: A Case Report and Prevalence in a Nationwide Population-Based Cohort Study. Journal of hematology 2023 1 11 (6): 233-239. Bhatti Khazra, Nazir Aqsa, Ostergaard Simon, Schejbel Lone, Norgaard Peter, Gjerdrum Lise M R, Moghaddas Mahnaz, Nielsen Torsten H, Munksgaard Lars, Pedersen Lars |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 01, 2023
- Content source: